Claes Glassell Appointed Cambrex Corporation President & Chief Operating Officer
Cambrex Corporation (NYSE: CBM), announced today the appointment of Claes Glassell as President and Chief Operating Officer. Mr. Glassell was also elected to the Cambrex Corporation Board of Directors.
Mr. Glassell joined Cambrex in 1994 through the Company’s acquisition of Nobel Pharma where he had been President since 1989. While at Cambrex, Mr. Glassell has held the positions of President - Pharmaceuticals Group and most recently Executive Vice President & Chief Operating Officer with responsibility for Cambrex’s Biosciences, Pharmaceutical and Fine Chemicals businesses. He has a Masters in Chemical Engineering from Chalmers University of Technology in Gothenberg, Sweden and is a graduate of the Advanced Management Program at Harvard University.
James A. Mack, Cambrex Chairman and Chief Executive Officer, said, “Claes has done an excellent job in building our pharmaceutical and biotechnology businesses. Cambrex’s focus continues to be on supplying proprietary products and services to the life sciences industry in support of drug discovery, development and commercial scale manufacturing. I look forward to working with Claes to implement our strategic plan and accelerate our growth.”
Cambrex Corporation primarily provides products and services to the life sciences industries.
Other news from the department
These products might interest you
Milli-Q® Services / MyMilli-Q™ by Merck Life Science
Services & Support for Water Purification Systems
Quality Care, Delivered. In Person & Online
Good Weighing Practice by Mettler-Toledo
Your Concrete Weighing Quality Assurance Plan
GWP Verification service
